Clinical Trial Update: ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ProAgio in previously treated advanced pancreatic cancer and other solid tumor malignancies; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Solid Tumor Malignancies

Drugs mentioned

• ProAgio

Snippet

Sponsor: ProDa BioTech, LLC | Conditions: Advanced Pancreatic Cancer, Solid Tumor Malignancies | Phase 1 | Status: ACTIVE_NOT_RECRUITING